NRIX- Nurix Therapeutics, Inc.

Name: Nurix Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nurix Therapeutics, Inc. (NRIX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NRIX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Hansen Gwenn	125.2K	$3.16M	-3,847
Other	Ring Christine	122.8K	$3.10M	-20,436
Dir	Dansey Roger D	50.0K	$1.26M	-
CFO	Van Houte Hans	40.2K	$1.01M	-7,606
Dir	Gregory Julia P	10.8K	$271.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 30, 2023	Van Houte Hans60	Chief Financial Officer	Sale+OE	924	$11.78	$10,884.35	-1.2%	-16.6%	-32.7%
Jan 30, 2023	Ring Christine77	General Counsel	Sale+OE	848	$11.78	$9,989.10	-10.5%	-16.6%	-32.7%
Jan 30, 2023	Hansen Gwenn72	Chief Scientific Officer	Sale+OE	1,412	$11.78	$16,632.80	-5.8%	-16.6%	-32.7%
Oct 31, 2022	Van Houte Hans60	Chief Financial Officer	Sale+OE	739	$12.88	$9,518.69	-1.0%	-6.8%	-56.1%
Oct 31, 2022	Ring Christine77	General Counsel	Sale+OE	699	$12.88	$9,003.47	-10.2%	-6.8%	-56.1%
Oct 31, 2022	Hansen Gwenn72	Chief Scientific Officer	Sale+OE	1,165	$12.88	$15,005.78	-5.2%	-6.8%	-56.1%
Oct 31, 2022	Wolff Stefani65	EVP And COO	Sale+OE	350	$12.88	$4,508.18	-9.3%	-6.8%	-56.1%
Aug 1, 2022	Wolff Stefani65	EVP And COO	Sale+OE	356	$15.67	$5,578.52	-22.3%	-17.4%	-38.4%
Aug 1, 2022	Van Houte Hans60	Chief Financial Officer	Sale+OE	752	$15.67	$11,783.84	-1.0%	-17.4%	-38.4%
Aug 1, 2022	Hansen Gwenn72	Chief Scientific Officer	Sale+OE	1,186	$15.67	$18,584.62	-5.8%	-17.4%	-38.4%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC